Sr. Medical Director, US Medical Affairs, Ophthalmology, Genentech, Inc.
February 25, 2026
Staying on schedule with wet age-related macular degeneration (AMD) treatment is one of the most important ways to protect your vision. In this episode, Manuel Amador, MD, explains today’s wet AMD treatments and why consistency matters. He will also share practical tips on early detection, risk factors, and taking an active role in your eye health.
Manuel Amador, MD, is a clinical epidemiologist, retina specialist, and medical director at Genentech’s US Medical Affairs Ophthalmology. He has dedicated his career to advancing the understanding of retinal diseases and addressing healthcare inequities. He is also medical lead for Elevatum, the first industry-sponsored retina trial focused on underrepresented populations in the U.S.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
In this Macular Chats episode, we break down the different types of implants in development and look ahead to what’s next in the research pipeline.
In recognition of National Caregivers Month, this episode explores the vital role of those who support individuals living with vision loss—whether family members, professionals, or volunteers.
Dr. Jeffrey Stern and Dr. Sally Temple, Principal Investigators and Co-Founders of the Neural Stem Cell Institute, will explain what stem cells are and share the latest updates from clinical trials.
Join Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue, and supporting daily visual function.
Help Fight Macular Degeneration and Save Sight
Your donation helps fund critical research to bring us closer to a cure for this sight-stealing disease and provide vital information to the public.
Donate Today
